Krystal Biotech (KRYS) executive compensation, 2026 proxy

Krish S. Krishnan, Chair and Chief Executive Officer, was paid $10.4M in 2025, down 33% from $15.6M the year before. The CEO-to-median-employee pay ratio was 62:1, on median employee pay of $168,440.

Filed
April 3, 2026
Annual meeting
May 15, 2026
Pay year
2025
Named executives
3
CEO total pay
$10.4M-33% vs prior year
CEO to median employee
62:1median $168,440
CEO pay in equity
84%$8.8M in awards
CEO 2025 Total Compensation
$10,442,485Decreased from prior year
Median Employee Pay
$168,4402025 total compensation
CEO Pay Ratio
62:1Based on 2025 compensation
CEO Target Bonus
80%Percentage of base salary

How Krishnan was paid

$10.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Bonus7%Stock awards39%Option awards45%All other compensation1%

Named executive officers

ExecutiveTotal
Krish S. KrishnanChair and Chief Executive Officer$10,442,485
Kathryn A. RomanoChief Accounting Officer$2,258,697
Suma M. KrishnanPresident, R&D$6,948,401

What changed and why

  • $15.6MCEO total compensation decreased from $15,603,652 in 2024 to $10,442,485 in 2025.
  • $4.1MStock awards for the CEO were $4,104,825 in 2025 compared to $13,953,625 in 2024.
  • $4.7MOption awards for the CEO were $4,675,093 in 2025 with no option awards granted in 2024.
  • $682KThe CEO received a bonus of $682,400 for 2025 compared to $714,560 for 2024.
  • $168KThe median employee total compensation for 2025 was $168,440 resulting in a pay ratio of 62 to 1.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.